Literature DB >> 35876870

Bloody pericardial effusion during chemotherapy with immune checkpoint inhibitors.

Yuika Sasatani1, Eiji Ojima2, Hiroaki Satoh3.   

Abstract

Entities:  

Year:  2022        PMID： 35876870     DOI： 10.1007/s00262-022-03261-x

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.630


× No keyword cloud information.
  3 in total

1.  Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports.

Authors:  Alessandro Inno; Nicola Maurea; Giulio Metro; Andreina Carbone; Antonio Russo; Stefania Gori
Journal:  Cancer Immunol Immunother       Date:  2021-04-20       Impact factor: 6.968

2.  Noninvasive evaluation of pericardial effusion composition by computed tomography.

Authors:  Robert D Rifkin; David B Mernoff
Journal:  Am Heart J       Date:  2005-06       Impact factor: 4.749

3.  Hyperprogressive disease in patients with non-small cell lung cancer treated with nivolumab: A case series.

Authors:  Masaki Kanazu; Ryuya Edahiro; Hiroyuki Krebe; Kohei Nishida; Mikako Ishijima; Takeshi Uenami; Yuki Akazawa; Yukihiro Yano; Toshihiko Yamaguchi; Masahide Mori
Journal:  Thorac Cancer       Date:  2018-10-17       Impact factor: 3.500
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.